http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010030821-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb72e002ed2d606901981aa74e5db187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de7c1a8154681def36fc24277647ce75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3eaed70713265977c5c4d4c5b51efe07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66bf9241573049a8f547817507011e90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a33c2b4ed2ad40fef7bf9029b51dac1c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2009-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b11dbf55ce557a4e4d741b53dffed77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b0b935d081bad04cb52938e90cc6c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45c005653979d5d2f67019b25f72d67e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145d16fd6f1dc82c31432b982a917f45
publicationDate 2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010030821-A2
titleOfInvention Ibuprofen for topical administration
abstract Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skm tissue Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e g, a pyrrohdone solvent or dimethylacetamide
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102854263-A
priorityDate 2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1588697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1621192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0439344-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03105804-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128048217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18939913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23618872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226590190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245707531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226817970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128732144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246558601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128483776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19069476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17848643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227610165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127624148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66705995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129001639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244052056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11557370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11512

Total number of triples: 79.